{
  "main_header": {
    "sid": 233635,
    "name": "Johnson Pharma",
    "stock_name": "Johnson Pharma",
    "full_name": "Johnson Pharmacare Ltd",
    "name_url": "stocks-analysis/johnson-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.98",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "0.98",
    "mcapval": "53.90 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532154,
    "symbol": "",
    "ind_name": "Trading",
    "ind_code": 49,
    "isin": "INE560F01022",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "01:19 AM",
    "bse_nse_vol": "11.56 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/johnson-pharma-233635-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 9,
    "sid": "233635",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/johnson-pharmacare-233635"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2025",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "21-Mar-2025",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 31St January 2025.",
      "datetime": "31-Jan-2025",
      "details": "Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Friday 31st January 2025 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter and nine months ended on 31st December 2024. The board meeting commented at 06:25 PM and concluded at 06:45 PM Please take the above intimation in your records. Thanking You",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Johnson Pharmacare Ltd has announced <strong>1:10</strong> stock split, ex-date: 05 Jan 22",
          "dt": "2022-01-05",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Johnson Pharmacare Ltd has announced <strong>1:10</strong> bonus issue, ex-date: 07 Apr 22",
          "dt": "2022-04-07",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News